Make cataract patients happier and stop worrying about compliance with "dropless" cataract surgery from Imprimis Pharmaceuticals. Many elderly patients struggle with placing eyedrops after surgery and comply poorly as a result. Now they don't have to; surgeons can inject sterile compounded formulations from Imprimis after implanting the IOL, obviating the need for drops. Two formulations are available: One containing triamcinolone and moxifloxacin, the other containing both agents plus vancomycin.
Your product information request has been received and we will forward information to the contact information you provided shortly.